BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31432643)

  • 1. Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay.
    Chung HJ; Hur M; Yoon S; Hwang K; Lim HS; Kim H; Moon HW; Yun YM
    Ann Lab Med; 2020 Jan; 40(1):72-75. PubMed ID: 31432643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.
    Shelton DN; Bhagavatula P; Sepulveda N; Beppu L; Gandhi S; Qin D; Hauenstein S; Radich J
    PLoS One; 2022; 17(3):e0265278. PubMed ID: 35298544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial diagnosis of chronic myelogenous leukemia based on quantification of M-BCR status using droplet digital PCR.
    Lund HL; Hughesman CB; McNeil K; Clemens S; Hocken K; Pettersson R; Karsan A; Foster LJ; Haynes C
    Anal Bioanal Chem; 2016 Feb; 408(4):1079-94. PubMed ID: 26631023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.
    Furuya D; Moriai M; Koizumi Y; Endo T; Asanuma K; Yanagihara N; Takahashi S
    Int J Clin Oncol; 2019 Jul; 24(7):871-875. PubMed ID: 30798394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Digital Droplet PCR for BCR-ABL.
    Maier J; Lange T; Cross M; Wildenberger K; Niederwieser D; Franke GN
    J Mol Diagn; 2019 Jan; 21(1):27-37. PubMed ID: 30347270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.
    Franke GN; Maier J; Wildenberger K; Cross M; Giles FJ; Müller MC; Hochhaus A; Niederwieser D; Lange T
    J Mol Diagn; 2020 Jan; 22(1):81-89. PubMed ID: 31669230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia.
    Martinez RJ; Kang Q; Nennig D; Bailey NG; Brown NA; Betz BL; Tewari M; Thyagarajan B; Bachanova V; Mroz P
    Arch Pathol Lab Med; 2022 Jan; 146(1):92-100. PubMed ID: 33769465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of two commercially available BCR-ABL1 quantification assays that use an international reporting scale.
    Seo SH; Lee SJ; Park S; Kim MJ; Song JY; Ra EK; Cho SI; Kim HK; Yang MG; Kim JY; Park SS; Seong MW
    Clin Chem Lab Med; 2016 Jul; 54(7):1157-60. PubMed ID: 26587743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients.
    Cortés AA; Olmedillas S; Serrano-López J; Lainez-González D; Castaño T; Iñiguez R; Lopez-Lorenzo JL; García A; Atance M; Sánchez RNS; Lopez CB; Arranz MG; Sillero PL; Alonso-Dominguez JM
    Mol Diagn Ther; 2020 Oct; 24(5):593-600. PubMed ID: 32875515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
    Scott S; Cartwright A; Francis S; Whitby L; Sanzone AP; Mulder A; Galimberti S; Dulucq S; Mauté C; Lauricella C; Salmon M; Rose S; Willoughby J; Boeckx N; Pallisgaard N; Maier J; Leibundgut EO; Zizkova H; Ling Goh L; Duong C; Tang WF; Ma E; Shivakumar Y; Beppu L; Bhagavatula P; Chantry A
    Br J Haematol; 2021 Jul; 194(1):53-60. PubMed ID: 34114218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.
    Jennings LJ; George D; Czech J; Yu M; Joseph L
    J Mol Diagn; 2014 Mar; 16(2):174-9. PubMed ID: 24389534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR].
    Yagasaki F; Niwa T; Abe A; Ishikawa M; Kato C; Ogura K; Sasaki H; Kyo T; Jinnai I; Bessyo M; Miyamura K
    Rinsho Ketsueki; 2009 Jun; 50(6):481-7. PubMed ID: 19571508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
    Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
    Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
    Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
    Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
    Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.
    Zagaria A; Anelli L; Coccaro N; Tota G; Casieri P; Cellamare A; Impera L; Brunetti C; Minervini A; Minervini CF; Delia M; Cumbo C; Orsini P; Specchia G; Albano F
    Virchows Arch; 2015 Sep; 467(3):357-63. PubMed ID: 26149409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
    Brown JT; Beldorth IJ; Laosinchai-Wolf W; Fahey ME; Jefferson KL; Ruskin AK; Roth JJ; Cai L; Watt CD; Press RD; Yang F; Hedges JB; Andruss BF
    J Mol Diagn; 2019 Jul; 21(4):718-733. PubMed ID: 31026597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new diagnostic kit, ODK-1201, for the quantitation of low major BCR-ABL mRNA level in chronic myeloid leukemia: correlation of quantitation with major BCR-ABL mRNA kits.
    Nakamae H; Yoshida C; Miyata Y; Hidaka M; Uike N; Koga D; Sogabe T; Matsumura I; Kanakura Y; Naoe T
    Int J Hematol; 2015 Sep; 102(3):304-11. PubMed ID: 26141653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA.
    Bartley PA; Ross DM; Latham S; Martin-Harris MH; Budgen B; Wilczek V; Branford S; Hughes TP; Morley AA
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e222-8. PubMed ID: 20491997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
    Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.